200 West Street,
New York , NY, 10282
New York , NY, 10282
Summary
The fund seeks to replicate the total return performance of the benchmark index, before fees and expenses, by investing in companies outside the United States.
The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.
Next, the research team invests significantly in securities included in More
Webiste
Directors
Nov 13, 2023- Lawrence Hughes
- Lawrence W. Stranghoener
- James A. McNamara
- Cheryl K. Beebe
- Steven D. Krichmar
- Michael Latham
- John F. Killian
Chief Compliance Officer
- Julien Yoo
Price
- $ 35.03 ( -0.16 )
-
Dec 09, 2024Last Close
- Net Assets
-
$3.5B
Apr 26, 2024
- 52-Week High/Low
- $35.1 - $33.8
- Expense Ratio
- -
Performance
YTD
0%
3 Year
3.31%
5 Year
18.13%
Best
77.87%
2003
Worst
-77.21%
2015
Company Name |
Holding |
Novo Nordisk A/S | 2.14 % |
GOLDMAN SACHS FINANCIAL SQUARE FUNDS PRIME OBLIGATIONS FUND | 1.45 % |
ASML Holding NV | 1.36 % |
Novartis AG | 1.1 % |
Nestle SA | 1.05 % |
Roche Holding AG | 1.04 % |
AstraZeneca PLC | 1.01 % |
SAP SE | 0.85 % |
LVMH Moet Hennessy Louis Vuitt | 0.82 % |
Shell PLC | 0.8 % |
More | 0.8 % |
Documents
NAV
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
GSIE | 0% | 5.7% | 13.5% | -16.7% | 10.9% | 2.9% | 19.8% | -13.4% | 26.2% | 2.4% | |
S&P 500 | 6.8% | 23.3% | 24.2% | -19.4% | 27.3% | 16.2% | 28.9% | -6.2% | 19.4% | 9.5% |
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
q1 | 0% | 5% | 7.1% | -5.2% | 3.5% | -23.8% | 11.1% | -0.3% | 7.8% | 0.2% | ||||
q2 | 0% | -0.2% | 1.8% | -15.2% | 8.4% | 15.3% | 1% | 1% | 6.8% | -0.5% | ||||
q3 | 0% | 0% | -4.2% | -10.9% | -2.2% | 4.1% | -1.5% | 2.1% | 5.2% | 5.4% | ||||
q4 | 0% | 0% | 10.6% | 16.3% | 3.2% | 12.4% | 6.9% | -13.6% | 4.1% | -2.5% |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
2024 | -0.4% | 2.6% | 2.7% | -3.2% | 4.1% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |